Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price reached a new 52-week high on Monday . The company traded as high as GBX 6.60 ($0.08) and last traded at GBX 6.30 ($0.08), with a volume of 370347 shares. The stock had previously closed at GBX 6.40 ($0.08).
Allergy Therapeutics Price Performance
The company has a current ratio of 1.40, a quick ratio of 1.48 and a debt-to-equity ratio of 37.22. The firm’s 50-day moving average price is GBX 5.37 and its 200-day moving average price is GBX 5.03. The stock has a market capitalization of £300.51 million, a PE ratio of -105.00, a PEG ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
- Five stocks we like better than Allergy Therapeutics
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- What Are Some of the Best Large-Cap Stocks to Buy?
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
